|
|
|
Volumn , Issue 3, 2006, Pages 117-131
|
|
An integrated approach to developing chemoenzymatic processes at the industrial scale.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG;
ENZYME;
FRUCTOSE BISPHOSPHATE ALDOLASE;
OXAZOLE DERIVATIVE;
PROTEINASE INHIBITOR;
PYRROLIDINE DERIVATIVE;
RUPINTRIVIR;
BACILLUS;
BIOTECHNOLOGY;
BIOTRANSFORMATION;
CATALYSIS;
CHEMICAL MODEL;
CHEMISTRY;
COST BENEFIT ANALYSIS;
DRUG DESIGN;
ENZYMOLOGY;
METHODOLOGY;
REVIEW;
STEREOISOMERISM;
THEORETICAL MODEL;
BACILLUS;
BIOTECHNOLOGY;
BIOTRANSFORMATION;
CATALYSIS;
CHEMISTRY, PHARMACEUTICAL;
COST-BENEFIT ANALYSIS;
DRUG DESIGN;
ENZYMES;
FRUCTOSE-BISPHOSPHATE ALDOLASE;
HIV PROTEASE INHIBITORS;
MODELS, CHEMICAL;
MODELS, THEORETICAL;
OXAZOLES;
PHARMACEUTICAL PREPARATIONS;
PYRROLIDINES;
STEREOISOMERISM;
|
|
EID: 34548491409
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (25)
|
